The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.
Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eleven closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.
Six of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in STEMTHERAPY, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.
Professor Margaret (Peggy) Goodell from Baylor College of Medicine, Houston, TX, USA will be visiting Lund on September 10-14. She will give a lecture entitled: ” DNA methyltransferase 3a in normal and malignant hematopoiesis” on September 11 at 14:00 in Segerfalk lecture hall, BMC A10.
This seminar is sponsored by Hemato-Linné and STEMTHERAPY.
Emma Rörby will defend her thesis entitled "Regulation of Hematopoietic Stem Cells" on September 12 at 13:00 in the Segerfalk Lecture Hall.
Faculty opponent: Professor Margaret (Peggy) Goodell, Baylor College of Medicine, Houston, TX, USA.
Main supervisor: Professor Stefan Karlsson
Miharada et al. could report the identification of a novel regulator of hematopoietic stem cell function, developmental pluripotency-associated 5 (Dppa5), in the latest volume of Cell Reports. Miharada and colleagues discovered a novel connection between endoplasmic reticulum stress and hematopoietic stem cell properties, implicating that protein quality control is critical for hematopoietic stem cell function in vivo and in vitro.